OpenURL Connection Search

Select item for more details and to access through your institution.

2417. Feasibility and Safety of Using a Probiotic Comprised of Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 for C. difficile Infection Prevention Among Antibiotic Users: 15-Years of Prospective Results from a Single-Center.
Published in:
Open Forum Infectious Diseases, 2019, v. 6, p. S834, doi. 10.1093/ofid/ofz360.2095
By:
- Maziade, Pierre-Jean;
- Lussier, Daniel;
- Dubé, Francoise
Publication type:
Article
Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes.
Published in:
Clinical Infectious Diseases, 2022, v. 74, n. 5, p. 941, doi. 10.1093/cid/ciab618
By:
- McFarland, Lynne V;
- Kullar, Ravina;
- Maziade, Pierre-Jean;
- Goldstein, Ellie J C
Publication type:
Article
Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Published in:
Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1524, doi. 10.1093/cid/ciab414
By:
- Maziade, Pierre-Jean;
- Ship, Noam;
- Sniffen, Jason C;
- Goldstein, Ellie J C
Publication type:
Article
A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Published in:
Clinical Infectious Diseases, 2015, v. 60, p. S144, doi. 10.1093/cid/civ178
By:
- Maziade, Pierre-Jean;
- Pereira, Pascale;
- Goldstein, Ellie J. C.
Publication type:
Article
Pathway to Prevention of Nosocomial Clostridium difficile Infection.
Published in:
Clinical Infectious Diseases, 2015, v. 60, p. S148, doi. 10.1093/cid/civ142
By:
- Goldstein, Ellie J. C.;
- Johnson, Stuart;
- Maziade, Pierre-Jean;
- McFarland, Lynne V.;
- Trick, William;
- Dresser, Linda;
- Millette, Mathieu;
- Mazloum, Hadi;
- Low, Donald E.
Publication type:
Article
Pathway to Prevention of Nosocomial Clostridium difficile Infection.
Published in:
Clinical Infectious Diseases, 2015, v. 60, p. S148, doi. 10.1093/cid/civ142
By:
- Goldstein, Ellie J. C.;
- Johnson, Stuart;
- Maziade, Pierre-Jean;
- McFarland, Lynne V.;
- Trick, William;
- Dresser, Linda;
- Millette, Mathieu;
- Mazloum, Hadi;
- Low, Donald E.
Publication type:
Article
A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Published in:
Clinical Infectious Diseases, 2015, v. 60, p. S144, doi. 10.1093/cid/civ178
By:
- Maziade, Pierre-Jean;
- Pereira, Pascale;
- Goldstein, Ellie J. C.
Publication type:
Article

Found: 7

2417. Feasibility and Safety of Using a Probiotic Comprised of Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 for C. difficile Infection Prevention Among Antibiotic Users: 15-Years of Prospective Results from a Single-Center.

Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes.

Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.

A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).

Pathway to Prevention of Nosocomial Clostridium difficile Infection.

Pathway to Prevention of Nosocomial Clostridium difficile Infection.

A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).